BioSpace News Archive

- New analysis from COMPASS examines the use of XARELTO® plus aspirin in reducing major adverse limb events in patients with peripheral artery disease - New CANVAS Program data assess the impact of INVOKANA® on heart failure in patients with T2D with an elevated risk of cardiovascular disease - Janssen leads in cardiovascular innovation using real-world data from wearable electrocardiogram sensors to detect asymptomatic atrial fibrillation

PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced that the Company has been recognized for its diverse and flexible workplace by Forbes and FlexJobs.

McKesson Specialty Health, a division of McKesson Corporation, announced a strategic collaboration with Cryoport, Inc. (NASDAQ: CYRX, CYRXW) designed to further strengthen its robust logistics services to support the delivery of cell and gene therapies to patients at the point of care.

Jeffrey Chodakewitz, M.D., to retire and serve as senior advisor through early 2019. Dr. Kewalramani to become CMO and Executive Vice President, Global Medicines Development and Medical Affairs, on April 1, 2018.

DanDrit Biotech USA, Inc. finalized its acquisition of Enochian Biopharma Inc. on February 16, 2018.

Will highlight various innovative analytical systems and new high-value solutions for food analysis, pharmaceutical, clinical research, and materials science applications.

Fasenra’s approval means physicians have a new option for severe asthma patients with a distinct phenotype.

Molecular Assemblies Inc. today announced the appointment of Kim F. Albizati, PhD, as vice president of chemistry and biochemistry.

Mr. Driscoll will serve on the audit committee.

Neumentum today announced it has confirmed its Type B meeting with the U.S. Food and Drug Administration (FDA).